Quantitative Drug Safety and Benefit Risk Evaluation

Du sparer 0% ift. normalprisen Spar 0%

Hardback
2-3 uger
1.789,95 kr.

Bag om Quantitative Drug Safety and Benefit Risk Evaluation

This book provides a comprehensive coverage on safety monitoring methodologies, covering both global trends and regional initiatives. Pharmacovigilance has traditionally focused on the handling of individual adverse event reports however recently there had been a shift towards aggregate analysis to better understand the scope of product risks.

Vis mere

Sprog:
Engelsk

ISBN:
9781138594067

Forlag:
Taylor & Francis Ltd

Indbinding:
Hardback

Sideantal:
382

Udgivet:
31. december 2021

Størrelse:
156x234x0 mm.

Vægt:
680 g.

Leveringstid: 2-3 uger.
Forventet levering: 12. december 2024

På lager

Normalpris

BLACK WEEK
1.789,95 kr. + Fragt
~~1.789,95 kr.~~

Medlemspris

1.739,95 kr.

Prøv i 30 dage for 45 kr.
Herefter fra 79 kr./md. Ingen binding.

Beskrivelse af Quantitative Drug Safety and Benefit Risk Evaluation

This book provides a comprehensive coverage on safety monitoring methodologies, covering both global trends and regional initiatives. Pharmacovigilance has traditionally focused on the handling of individual adverse event reports however recently there had been a shift towards aggregate analysis to better understand the scope of product risks.

Brugerbedømmelser af Quantitative Drug Safety and Benefit Risk Evaluation

Andre købte også..

Find lignende bøger

Bogen Quantitative Drug Safety and Benefit Risk Evaluation findes i følgende kategorier:

Business og læring

Quantitative Drug Safety and Benefit Risk Evaluation - Bog

Beskrivelse af Quantitative Drug Safety and Benefit Risk Evaluation

Brugerbedømmelser af Quantitative Drug Safety and Benefit Risk Evaluation

Gør som tusindvis af andre bogelskere